Uji Potensi Triterpenoid dari Kulit Batang Waru Jawa (Hibiscus tiliaceus L.) sebagai Kandidat Antiinflamasi pada Mencit (Mus musculus) Model Rheumatoid Arthritis Berbasis in Silico

Lisa Savitri, Elfred Rinaldo Kasimo, Datin An Nisa Sukmawati, Syntia Tanu Juwita, Eka Wahyuningtiyas, Ana Retnowati


Waru jawa (Hibiscus tiliaceus L.) is a plant that functions as an anti-inflammatory. Compounds from the waru jawa plant, especially the bark can be grouped into alkaloids, flavonoids, triterpenoids, and steroids. The content of triterpenoids from the waru jawa stem bark was tested for their biochemical activity, so that it is expected that the bark of Javanese waru stems can be used optimally. This study aims to determine the potential of triterpenoids from waru jawa stem bark as anti-inflammatory candidates in mice (Mus musculus) rheumatoid arthritis model in silico-based. Potential analysis of triterpenoids in mice was carried out using the STITCH, which is a database of known and predicted interactions between chemicals and proteins found in living things. Interactions in question are physical and functional associations, the data contained in STITCH comes from computational predictions, transfer of knowledge between organisms, and from interactions collected from other databases. Analysis of the triterpenoid mechanism of waru jawa stem bark against rheumatoid arthritis model mice in silico-based using the bioinformatics application Kegg. Based on the results of the analysis, it can be seen that triterpenoids derived from waru jawa stem bark sources play an important role in reducing inflammation. The triterpenoids target NF-κB, leading to its downregulation. Triterpenoids have been found to have many functions, although their effective concentrations for various cellular effects may vary widely. Depending upon the dose administered, triterpenoids can induce anti-inflammatory, proliferation-arresting, apoptotic effects, cytoprotective, and tumor-differentiating.


waru jawa stem bark; triterpenoid; rheumatoid arthritis; in silico

Full Text:



Aggarwal B.B., Vijayalekshmi R.V., Sung B. Targeting inflammatory pathways for prevention and therapy of cancer: short- term friend, long-term foe. Clin. Cancer Res. 2009;15:425–430.

Ashok, K. & Gaur, A. 2014. Review Article: Remembering Cyclooxygenases: A Brief Review. Asian Journal of Pharmaceutical Technology and Innovation, 2 (4): 1-8.

Garg A., Aggarwal B.B. Nuclear transcription factor-kappaB as a target for cancer drug development. Leukemia. 2002;16:1053–1068.

Coussens L.M., Werb Z. Inflammation and cancer. Nature. 2002;420:860–867.

Balkwill F., Charles K.A., Mantovani A. Smoldering and polarized inflammation in the initiation and promotion of malignant disease. Cancer Cell. 2005;7:211–217.

Gupta, V. & Yadav, S.K. 2011. Review Article: Cyclooxygenase-2: Pathway from Anti Inflammatory to Anti-Cancer Drugs. International Journal of Pharmacy and Life Sciences, 2(2): 571-582.

Hayden M.S., Ghosh S. Signaling to NF-kappaB. Genes Dev. 2004;18:2195–2224.

Janssens S., Tschopp J. Signals from within: the DNA-damage-induced NF-kappaB response. Cell Death Differ. 2006;13:773–784.

Kamiensky, M. & Keogh J. 2006. Vitamin and Minerals. In: Pharmacology Demystified. USA: Mc.GrawHill Companies Inc.

Karin M., Cao Y., Greten F.R., Li Z.W. NF kappaB in cancer: from innocent by stander to major culprit. Nat. Rev. Cancer. 2002;2:301-310.

Mariler, M.M. & Eggimann, B.S. 2005. The Prevalence of Rheumatic Diseases in Elderly in Developed Countries an Its Evolution over Time. Int. J. of Public Health, 50 (1): 45-51.

Nathan C. Points of control in inflammation. Nature. 2002;420:846–852.

Savitri, L. & Ihsan, K. Aktivitas Triterpenoid Kulit Batang Waru Jawa (Hibiscus tiliaceus L.) terhadap Bakteri Escherichia coli. Jurnal Kesehatan Perintis (Perintis’s Health Journal), 7 (1) 2020: 41-50

Savitri, L. & Ihsan, K. Uji Aktivitas Triterpenoid Kulit Batang Waru Jawa (Hibiscus tiliaceus L.) terhadap Staphylococcus aureus. TEKLABMED Jurnal Teknologi Laboratorium Medik, 1 (1) 2020: 13-20.

Smith, W.L., Garavito, R.M., & DeWitt, D.L. 1996. Minireview: Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and - 2. The Journal of Biological Chemistry, 271 (52): 33157-33160.

Symmons, D., Mathers, C., & Pfleger, B. 2006. The Global Burden Rheumatoid Arthritis in the Year 2000. Global Burden of Disease 2000.

Tian Z., Yang M., Huang F., Li K., Si J., Shi L., Chen S., Xiao P. Cytotoxicity of three cycloartane triterpenoids from Cimicifuga dahurica. Cancer Lett. 2005;226:65–75.

Tobon, G.J., Youinou, P., & Saraux, A. 2009. Autoimmunity Reviews: the Environment, Geo-Epidemiology, and Autoimmune Disease: Rheumatoid Arthritis. Brest: Elsevier.

Ulrich C.M., Potter J.D. Testing for colon neoplasia susceptibility variants at the human Cox2 locus. J. Natl. Cancer Inst. 2001;93:1572–1574.

Vivek R. Yadav, Sahdeo Prasad, Bokyung Sung, Ramaswamy Kannappan, and Bharat B. Aggarwal. Targeting Inflammatory Pathways by Triterpenoids for Prevention and Treatment of Cancer. Toxins (Basel). 2010 Oct; 2(10): 2428 2466.

Wong, R., Davis, A.M., Badley, E., Grewal, R., & Mohammed, M. 2010. Prevalence of Arthritis and Rheumatic Diseases Around the World a Growing Burden and Implications for Health Care Needs. Toronto: Arthritis Community Research and Evaluation Unit.

Xie K. Interleukin-8 and human cancer biology. Cytokine Growth Factor Rev. 2001;12:375–391.

DOI: http://dx.doi.org/10.33087/jiubj.v21i3.1619


  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.


Published by Lembaga Penelitian dan Pengabdian kepada Masyarakat
Adress: Jl.Slamet Ryadi, Broni-Jambi, Kec.Telanaipura, Kodepos: 36122, email: jiubj.unbari@gmail.com, Phone: 0741-670700

Creative Commons License This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.